Stereotactic Arrhythmia Radioablation (STAR): A Multidisciplinary Narrative Minireview of Preclinical Studies

Overview

Journal In Vivo

Specialty Oncology

Date 2023 Apr 27

PMID 37103087

Authors

Erika Galietta

Silvia Strolin

Silvia Bisello

Francesco Cellini

Luigi Lovato

Gloria Ravegnini

Cristian Martignani

Alberto Spadotto

Milly Buwenge

Silvia Cammelli

Lidia Strigari

Alessio G Morganti

Alessandra Arcelli

Affiliations

Soon will be listed here.

Abstract

The aim of this narrative review of the literature was to collect and analyze the results of the published preclinical studies on stereotactic arrhythmia radioablation (STAR) in the treatment of refractory cardiac arrhythmias. A literature search was conducted on PubMed using the following terms: ("stereotactic" OR "SBRT" OR "SABR" OR "radioablation" OR "radiosurgery") AND ("arrhythmia" OR "tachycardia"). Preclinical and pathological reports published in English without time limit, comprising studies of STAR in animal models and histological analyzes of explanted animal and human hearts were included. The analyzed studies confirm that doses lower than 25 Gy seem to produce sub-optimal therapeutic results whereas doses >35 Gy are less safe in terms of radiation-induced toxicity. However, long-term results (>1 year) are still missing and reporting outcomes based on low dose irradiation (≤15 Gy). Finally, STAR proved to be an effective therapy in the analyzed studies despite the irradiation of rather different cardiac targets. Therefore, additional studies are needed to: 1) compare the outcomes of STAR at doses of 25 Gy versus 30 Gy; 2) evaluate the long-term results (>1 year) in animal models irradiated at doses similar to those used in the clinic; 3) define the optimal target.

References

Refaat M, Zakka P, Youssef B, Zeidan Y, Geara F, Al-Ahmad A . Noninvasive Cardioablation. Card Electrophysiol Clin. 2019; 11(3):481-485. DOI: 10.1016/j.ccep.2019.05.008. View

Amino M, Yamazaki M, Yoshioka K, Kawabe N, Tanaka S, Shimokawa T . Heavy Ion Irradiation Reduces Vulnerability to Atrial Tachyarrhythmias　- Gap Junction and Sympathetic Neural Remodeling. Circ J. 2022; 87(7):1016-1026. DOI: 10.1253/circj.CJ-22-0527. View

Lehmann H, Graeff C, Simoniello P, Constantinescu A, Takami M, Lugenbiel P . Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion Beams. Sci Rep. 2016; 6:38895. PMC: 5171237. DOI: 10.1038/srep38895. View

Jumeau R, Ozsahin M, Schwitter J, Elicin O, Reichlin T, Roten L . Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions. Front Cardiovasc Med. 2020; 7:108. PMC: 7329991. DOI: 10.3389/fcvm.2020.00108. View

Wei C, Qian P, Tedrow U, Mak R, Zei P . Non-invasive Stereotactic Radioablation: A New Option for the Treatment of Ventricular Arrhythmias. Arrhythm Electrophysiol Rev. 2020; 8(4):285-293. PMC: 7358955. DOI: 10.15420/aer.2019.04. View

Ho G, Atwood T, Bruggeman A, Moore K, McVeigh E, Villongco C . Computational ECG mapping and respiratory gating to optimize stereotactic ablative radiotherapy workflow for refractory ventricular tachycardia. Heart Rhythm O2. 2021; 2(5):511-520. PMC: 8505208. DOI: 10.1016/j.hroo.2021.09.001. View

Zei P, Wong D, Gardner E, Fogarty T, Maguire P . Safety and efficacy of stereotactic radioablation targeting pulmonary vein tissues in an experimental model. Heart Rhythm. 2018; 15(9):1420-1427. DOI: 10.1016/j.hrthm.2018.04.015. View

Sharma A, Wong D, Weidlich G, Fogarty T, Jack A, Sumanaweera T . Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium. Heart Rhythm. 2010; 7(6):802-10. DOI: 10.1016/j.hrthm.2010.02.010. View

Benali K, Bellec J, Jaksic N, Caille P, Rigal L, Simon A . Cardiac stereotactic ablative radiotherapy for refractory ventricular arrhythmias: A radical alternative? A narrative review of rationale and cardiological aspects. J Med Imaging Radiat Sci. 2021; 52(4):626-635. DOI: 10.1016/j.jmir.2021.09.007. View

10.

Cuculich P, Schill M, Kashani R, Mutic S, Lang A, Cooper D . Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia. N Engl J Med. 2017; 377(24):2325-2336. PMC: 5764179. DOI: 10.1056/NEJMoa1613773. View

11.

Miszczyk M, Sajdok M, Nozynski J, Cybulska M, Bednarek J, Jadczyk T . Histopathological Examination of an Explanted Heart in a Long-Term Responder to Cardiac Stereotactic Body Radiotherapy (STereotactic Arrhythmia Radioablation). Front Cardiovasc Med. 2022; 9:919823. PMC: 9302025. DOI: 10.3389/fcvm.2022.919823. View

12.

Yugo D, Lo L, Wu Y, Chung F, Lin Y, Chang S . Case series on stereotactic body radiation therapy in non-ischemic cardiomyopathy patients with recurrent ventricular tachycardia. Pacing Clin Electrophysiol. 2021; 44(6):1085-1093. DOI: 10.1111/pace.14254. View

13.

Amino M, Yoshioka K, Furusawa Y, Tanaka S, Kawabe N, Hashida T . Inducibility of Ventricular Arrhythmia 1 Year Following Treatment with Heavy Ion Irradiation in Dogs with Myocardial Infarction. Pacing Clin Electrophysiol. 2017; 40(4):379-390. DOI: 10.1111/pace.13031. View

14.

Qian P, Quadros K, Aguilar M, Wei C, Boeck M, Bredfeldt J . Substrate Modification Using Stereotactic Radioablation to Treat Refractory Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy. JACC Clin Electrophysiol. 2021; 8(1):49-58. DOI: 10.1016/j.jacep.2021.06.016. View

15.

Refaat M, Ballout J, Zakka P, Hotait M, Al Feghali K, Gheida I . Swine Atrioventricular Node Ablation Using Stereotactic Radiosurgery: Methods and In Vivo Feasibility Investigation for Catheter-Free Ablation of Cardiac Arrhythmias. J Am Heart Assoc. 2017; 6(11). PMC: 5721791. DOI: 10.1161/JAHA.117.007193. View

16.

Amino M, Yoshioka K, Tanabe T, Tanaka E, Mori H, Furusawa Y . Heavy ion radiation up-regulates Cx43 and ameliorates arrhythmogenic substrates in hearts after myocardial infarction. Cardiovasc Res. 2006; 72(3):412-21. DOI: 10.1016/j.cardiores.2006.09.010. View

17.

Lehmann H, Richter D, Prokesch H, Graeff C, Prall M, Simoniello P . Atrioventricular node ablation in Langendorff-perfused porcine hearts using carbon ion particle therapy: methods and an in vivo feasibility investigation for catheter-free ablation of cardiac arrhythmias. Circ Arrhythm Electrophysiol. 2015; 8(2):429-38. DOI: 10.1161/CIRCEP.114.002436. View

18.

Lee J, Bates M, Shepherd E, Riley S, Henshaw M, Metherall P . Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience. Open Heart. 2021; 8(2). PMC: 8611439. DOI: 10.1136/openhrt-2021-001770. View

19.

Kucera T, Jedlickova K, Sramko M, Peichl P, Cvek J, Knybel L . Inflammation and fibrosis characterize different stages of myocardial remodeling in patients after stereotactic body radiotherapy of ventricular myocardium for recurrent ventricular tachycardia. Cardiovasc Pathol. 2022; 62:107488. PMC: 9760563. DOI: 10.1016/j.carpath.2022.107488. View

20.

Amino M, Yoshioka K, Fujibayashi D, Hashida T, Furusawa Y, Zareba W . Year-long upregulation of connexin43 in rabbit hearts by heavy ion irradiation. Am J Physiol Heart Circ Physiol. 2010; 298(3):H1014-21. DOI: 10.1152/ajpheart.00160.2009. View